Screening for gynecologic cancer

Medical Clinics of North America

Volumn 83, Issue 6, 1999, Pages 1467-1487

  Zanotti, K M ^a   Kennedy, A W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; OVARY CARCINOMA; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

EID: 0032696159     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70175-9     Document Type: Article

References (73)

1. ACOG Technical Bulletin: Cervical cytology: Evaluation and management of abnormalities. No. 183, Aug 1993
2. R.R. Barakat R.C. Park P.W. Grigsby Corpus: Epithelial tumors Hoskens W.J. Perez C.A. Young R.C. Principles and Practice of Gynecologic Oncology ed 2 1996 Lippincott-Raven Philadelphia 859 896
3. J.O.W. Beilby R. Bourne J. Guillebaud Paired cervical smears: A method of reducing the false-negative rate in population screening Obstet Gynecol 40 1982 46
4. J.L. Benedet M.B. Anderson J.P. Matisic A comprehensive program for cervical cancer detection and management Am J Obstet Gynecol 144 1992 1254 1259
5. R.L. Blaustein Cytology of the female genital tract Kurman R.J. Blaustein's Pathology of the Female Genital Tract ed 3 1982 Springer Verlag New York
6. J.V. Bokhman Two pathogenic types of endometrial carcinoma Gynecol Oncol 15 1983 10
7. T. Bourne M.I. Whitehead S. Campbell Ultrasound screening for familial ovarian cancer Gynecol Oncol 43 1991 92 97
8. S. Broder The Bethesda System for reporting cervical/vaginal cytologic diagnoses— report of the 1991 Bethesda workshop JAMA 267 1992 1892
9. J.R. Burke H.F. Lehman F.S. Wolf Inadequacy of Papanicolaou smears in the detection of endometrial cancer N Engl J Med 291 1974 191 192
10. W. Burke M. Daly J. Garber Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA-1 and BRCA-2 JAMA 277 1997 997 1003
11. W. Burke G. Petersen P. Lynch Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer JAMA 277 1997 915 919
12. Cancer Facts and Figures 1998 The American Cancer Society Atlanta, GA
13. S. Ciatto S. Cecchini R. Bonardi A feasibility study of screening for endometrial carcinoma in postmenopausal women by ultrasonography Tumori 81 1995 334 337
14. E.A. Clarke T.W. Anderson Does screening by “Pap” smear help prevent cervical cancer? A case-control study Lancet 2 1979 1 4
15. T.J. Colgan S.F. Patten J.S.J. Lee A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory Acta Cytol 39 1996 1191 1198
16. D.W. Cramer G.B. Hutchinson W.R. Welch Determinants of ovarian cancer risk: I. Reproductive experiences and family history J Natl Cancer Inst 71 1983 711 716
17. P.D. DePriest H.H. Gallion E.J. Pavlik Transvaginal sonography as a screening method for detection of early ovarian cancer Gynecol Oncol 65 1997 408 414
18. M.A. Dewar K. Hall J. Perchalski Cervical cancer screening: Past success and future challenge Prim Care 19 1992 589
19. G.J. Draper G.A. Cook Changing patterns of cervical cancer rates BMJ 287 1983 510
20. M.C. Fahs J. Mandelblatt C. Schechter Cost effectiveness of cervical cancer screening for the elderly Ann Intern Med 117 1992 520
21. G. Fait Y. Daniel M.J. Kupferminc Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities? Gynecol Oncol 70 1998 319 322
22. B. Fisher J.P. Costantino C.K. Redmond Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 J Natl Cancer Inst 86 1994 527 537
23. J. Gay L. Donaldson J. Goellner False-negative results in cervical cytologic studies Acta Cytol 29 1989 1043 1046
24. L.E. Gibson R.R. Barakat E.S. Venkatraman Endometrial pathology at dilatation and curettage in breast cancer patients: Comparison of tamoxifen users and nonusers Cancer J Sci Am 2 1992 35 39
25. S. Granberg M. Wikland B. Karlsson Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality Am J Obstet Gynecol 164 1991 47 52
26. S.M. Greenwood D.J. Wright Evaluation of the office endometrial biopsy in detection of endometrial cancer and atypical hyperplasia Cancer 43 1979 1474 1478
27. G. Gullotta P.A. Margariti C. Rabitti Cytology, histology, and colposcopy in the diagnosis of neoplastic non-invasive epithelial lesions of the cervix Eur J Gynecol Oncol 18 1997 36 38
28. K.D. Hatch A. Schneider M.W. Abdel-Nour An evaluation of human papillomavirus testing for intermediate and high risk types as triage before colposcopy Am J Obstet Gynecol 172 1995 1150 1157
29. Higgins R.V. van Nagell J.R. C.H. Woods Interobserver variation in ovarian measurements using transvaginal sonography Gynecol Oncol 39 1990 69 71
30. T.R. Holbert Screening transvaginal ultrasonography of postmenopausal women in a private office setting Am J Obstet Gynecol 170 1994 1699 1703
31. I. Jacobs R. Bast The Ca125 tumor associated antigen: A review of the literature Hum Reprod 4 1989 1 12
32. I. Jacobs A.P. Davies J. Bradges Prevalence screening for ovarian cancer in postmenopausal women by Ca125 measurement and ultrasonography BMJ 306 1991 1030 1034
33. H.W. Jones Impact of the Bethesda system Cancer 76 10 suppl 1995 1914 1918
34. T. Julian The minimally abnormal pap smear and cervical cancer screening Colposcopist 25 1993 3
35. B. Karlsson S. Granberg M. Wiklandd Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study Am J Obstet Gynecol 172 1995 1488 1492
36. A.W. Kennedy S.S. Salmieri S.L. Wirth Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening Gynecol Oncol 63 1994 14 18
37. S. Keyhani-Rofagha T. Palma R. O'Toole Automated screening for quality control using Papnet: A study of 638 negative Pap smears Diagn Cytopathol 14 1996 316 320
38. L.G. Koss K. Schreiber S.G. Oberlander Detection of endometrial carcinoma and hyperplasia in asymptomatic women Obstet Gynecol 64 1984 1 11
39. H.L. Kottmeier Evolution et traiment des epitheliomas Rev Fr Gynecol Obstet 56 1961 821
40. B.A. Krumholz Presidential address: American Society for Colposcopy and Cervical Pathology Biennial Meeting, March 24, 1994, Orlando, Florida Colposcopist 26 1994 1
41. A. Kurjak H. Shalan S. Kupesic An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography J Ultrasound Med 13 1994 295 301
42. R.J. Kurman P.F. Kominski H.J. Norris The behavior of endometrial hyperplasia: A long-term study of “untreated” hyperplasia in 170 patients Cancer 56 1985 403 412
43. R.J. Kurman D.E. Henson A.L. Herbst Interim guidelines for management of abnormal cervical cytology JAMA 271 1994 1866
44. E. Laara N.E. Day M. Hakama Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programs Lancet 1 1987 1247 1249
45. La Vecchia C. S. Franceschi A. Decarli Pap smear and the risk of cervical neoplasia: Quantitative estimates from a case-control study Lancet 2 1984 779 782
46. K.R. Lee L.J. Minter S.R. Granter Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix: A study of 34 cases Am J Clin Pathol 107 1997 30 35
47. G.D. Lundberg The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses JAMA 262 1989 931 934
48. J.S. Mandelblatt R.N. Phillips Cervical cancer: How often—and why—to screen older women Geriatrics 51 1996 45 48
49. F. Montz B. Monk J. Fowler Natural history of the minimally abnormal Papanicolaou smear Obstet Gynecol 80 1992 385 388
50. Mulligan N.J. de las Morenas A. V. Soto-Wright Percentages of cervical cytologic diagnoses as a quality assurance method Acta Cytol 42 1998 928 932
51. K. Nasiell V. Roger M. Nasiell Behavior of mild cervical dysplasia during long-term follow-up Obstet Gynecol 67 1986 655 669
52. V.G. Palerma Interpretation of endometrium obtained by the Endo-pap sampler and a clinical study of its use Diagn Cytopathol 1 1985 5 12
53. K.F. Pearce H.K. Haefner S.F. Sarwar Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease N Engl J Med 335 1996 1559 1562
54. R. Pretorius N. Semrad W. Watring Presentation of cervical cancer Gynecol Oncol 42 1991 48 53
55. A. Reles U. Wein W. Lichtenegger Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses J Clin Ultrasound 25 1997 217 225
56. Ries L.A.G. Kosary C.L. Hankey B.F. SEER Cancer Statistics Review, 1973–1995 1998 National Cancer Institute Bethesda, MD
57. M.H. Rodriguez L.D. Plat A.L. Medearis The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology Am J Obstet Gynecol 158 1988 810
58. S. Rolnick J.J. LaFerla D. Wehrle Pap smear screening in a health maintenance organization: 1986–1990 Prev Med 25 1996 156 161
59. C.B. Schechter Cost effectiveness of rescreening conventionally prepared cervical smears by PapNet testing Acta Cytol 40 1996 1272 1282
60. J.M. Schildkraut W.D. Thompson Familial ovarian cancer: A population-based case control study Am J Epidemiol 128 1988 456 466
61. V.L. Schneider A. Schneider K.L. Reed Comparison of Doppler with two-dimensional sonography and Ca125 for prediction of malignancy of pelvic masses Obstet Gynecol 81 1993 983 988
62. H. Shingleton J. Orr Screening Cancer of the Cervix 1995 Lippincott-Raven Philadelphia 17 35
63. C.F. Shipley C.L. Simmons G.H. Nelson Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women J Ultrasound Med 13 1994 99 104
64. K. Sigurdsson Effect of organized screening on the risk of cervical cancer: Evaluation of screening activity in Iceland, 1964–1991 Int J Cancer 21 1993 563 570
65. L.H. Smith R.H. Oi Detection of malignant ovarian neoplasms: A review of the literature: I. Detection of the patient at risk; clinical, radiological and cytological detection Obstet Gynecol Surv 39 1984 313 328
66. M. Spitzer Cervical screening adjuncts: Recent advances Am J Obstet Gynecol 179 1998 544 556
67. E. Sprenger P. Schwarzmann M. Kirkpatrick The false negative rate in cervical cytology: Comparison of monolayers to conventional smears Acta Cytol 40 1996 81 89
68. T.G. Stovall F.W. Ling P.L. Morgan A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette Am J Obstet Gynecol 165 5 pt 1 1991 1287 1290
69. K. Syrjanen V. Kataja M. Yliskoski Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system Obstet Gynecol 79 1992 675 682
70. A.S. Whittemore R. Harris J. Itnyre Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group Am J Epidemiol 136 1992 1184 1203
71. J.M.G. Wilson G. Jungner Principles and Practice of Screening for Disease 1968 World Health Organization Geneva
72. C. Wright R.M. Richart Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract Hoskens W.J. Perez C.A. Young R.C. Principles and Practice of Gynecologic Oncology ed 2 1996 Lippincott-Raven Philadelphia 679
73. Y. Xu S. Zhongzhou D.W. Wiper Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic malignancies JAMA 280 1998 719 723